JAZZ News
Jazz Pharmaceuticals plc
$216.75
-$1.67(-0.76%)
55
Overall
60
Value
45
Tech
60
Quality
Market Cap
$14.18B
Volume
740.50K
52W Range
$128.80 - $266.38
Target Price
$295.64
JAZZ news: the latest Jazz Pharmaceuticals plc headlines, press releases and market updates, newest first.
Latest JAZZ News
- Barclays Keeps Their Buy Rating on Jazz Pharmaceuticals (JAZZ)TipRanks Auto-Generated Intelligence Newsdesk · Oct 13, 2026
- Jazz Pharmaceuticals Plans Commercial Leadership Transition AheadTipRanks Auto-Generated Newsdesk · Oct 9, 2026
- ADPT, MRNA, CRWV, NBIS, JAZZ trending with analystsTipRanks Weekend Auto-Generated Newsdesk · Oct 3, 2026
- Jazz Builds Real-World Case for Zanidatamab in Advanced HER2+ Gastroesophageal CancerTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 2, 2026
- Bernstein Reaffirms Their Hold Rating on Jazz Pharmaceuticals (JAZZ)TipRanks Auto-Generated Intelligence Newsdesk · Sep 26, 2026
- Jazz Pharmaceuticals Refinances Term Loan, Extends MaturitiesTipRanks Auto-Generated Newsdesk · Sep 23, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JAZZ | $216.75 | -0.8% | 740.50K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Jazz Pharmaceuticals plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW